Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study (Q33324037)

25 July 2017

Effectiveness of pneumococcal vaccination in older adults with chronic respiratory diseases: results of the EVAN-65 study (English)

1 reference

25 July 2017

Olga Ochoa-Gondar

1

0 references

Frederic Gomez

object named as

Frederic Gomez

8

0 references

Angel Vila-Córcoles

object named as

Angel Vila-Corcoles

2

0 references

Teresa Rodriguez-Blanco

object named as

T Rodriguez-Blanco

4

0 references

author name string

Xavier Ansa

3

1 reference

25 July 2017

Elisabeth Salsench

5

1 reference

25 July 2017

Cinta de Diego

6

1 reference

25 July 2017

Xavier Raga

7

1 reference

25 July 2017

Empar Valdivieso

9

1 reference

25 July 2017

Cruzma Fuentes

10

1 reference

25 July 2017

Laura Palacios

11

1 reference

25 July 2017

EVAN Study Group

12

1 reference

25 July 2017

language of work or name

English

0 references

publication date

27 February 2008

1 reference

25 July 2017

1 reference

25 July 2017

26

1 reference

25 July 2017

16

1 reference

25 July 2017

1955-1962

1 reference

Invasive pneumococcal disease in Dallas County, Texas: results from population-based surveillance in 1995.

25 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

The epidemiology of invasive Streptococcus pneumoniae disease in Catalonia (Spain). A hospital-based study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Pneumococcal vaccination: current and future issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Community-acquired pneumonia in chronic obstructive pulmonary disease: a Spanish multicenter study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Community-acquired pneumonia in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Risk factors for acquiring pneumococcal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Efficacy of polysaccharide pneumococcal vaccine in adults in more developed countries: the state of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

The health and economic benefits associated with pneumococcal vaccination of elderly persons with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Clinical efficacy of anti-pneumococcal vaccination in patients with COPD.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Protective effect of pneumococcal vaccine against death by pneumonia in elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Protective Effects of the 23‐Valent Pneumococcal Polysaccharide Vaccine in the Elderly Population: The EVAN‐65 Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Prognosis and outcomes of patients with community-acquired pneumonia. A meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

A prediction rule to identify low-risk patients with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Contribution of a urinary antigen assay (Binax NOW) to the early diagnosis of pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Community-acquired pneumonia in the elderly: Spanish multicentre study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Effect of prior pneumococcal vaccination on clinical outcome of hospitalized adults with community-acquired pneumococcal pneumonia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Barriers and facilitators of pneumococcal vaccination among the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Role of T lymphocyte replicative senescence in vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

Pneumococcal vaccine--direct and indirect ("herd") effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.02.021

10.1016/J.VACCINE.2008.02.021

7 January 2021

Identifiers

DOI

1 reference

25 July 2017

1 reference